首页> 外文OA文献 >Hypermethylation of GpG islands in the promoter region of p15INK4b in acute promyelocytic leukemia represses p15INK4b expression and correlates with poor prognosis
【2h】

Hypermethylation of GpG islands in the promoter region of p15INK4b in acute promyelocytic leukemia represses p15INK4b expression and correlates with poor prognosis

机译:急性早幼粒细胞白血病中p15INK4b启动子区域的GpG岛的甲基化抑制p15INK4b的表达并与不良预后相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We evaluated the methylation status of p15 gene in a series of 65 patients with newly diagnosed acute promyelocytic leukemia (APL) receiving homogeneous treatment. Moreover, in 32 of them, the methylation status of p15 gene was correlated to the p15 m-RNA expression. In total, 31 patients had no p15 methylation (U group). An abnormal methylation pattern was found in 34 patients: in seven of these patients only methylated DNA was detected (M group), while in the remaining 27 patients (M/U group), both methylated and unmethylated DNA were amplified. Patients from M group showed a higher incidence of relapses and a lower disease-free survival (DSF) with respect to patients from U and M/U groups (29, 64 and 79% at 5 years for M, U/M and U patients, respectively, P=0.03), while p15 methylation had no impact on overall survival. The p15 expression was detectable in all patients with unmethylated DNA, in none of patients with fully methylated DNA and in 60% of patients with partially methylated DNA. The DFS estimate at 5 years for p15-negative patients was significantly lower than that of p15-positive patients (P=0.03). These data confirm that the presence of p15 methylation negatively influences the prognosis of APL, mainly when it represses the p15 gene transcription.
机译:我们评估了65例接受均一治疗的新诊断为急性早幼粒细胞白血病(APL)的患者中p15基因的甲基化状态。而且,在其中的32个中,p15基因的甲基化状态与p15m-RNA表达相关。共有31例患者未出现p15甲基化(U组)。在34位患者中发现了异常的甲基化模式:在这些患者中,有7位仅检测到甲基化的DNA(M组),而在其余27位患者(M / U组)中,甲基化和未甲基化的DNA均被扩增。与U和M / U组相比,M组患者表现出更高的复发率和更低的无病生存率(M,U / M和U患者在5年时分别为29%,64%和79% ,分别为P = 0.03),而p15甲基化对总体生存没有影响。在所有未甲基化的DNA患者中,未检测到完全甲基化的DNA患者中和未检测到部分甲基化的DNA的患者中有60%检测到p15表达。 p15阴性患者在5年时的DFS估计值显着低于p15阳性患者(P = 0.03)。这些数据证实,p15甲基化的存在对APL的预后产生负面影响,主要是当它抑制p15基因转录时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号